Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 3 2Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 52Neoplasms, Plasma Cell 5Neoplasms 4Lymphoma 4Waldenstrom Macroglobulinemia 3Recurrence 3Hematologic Neoplasms 3Prostatic Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Lymphocytic, Chronic, B-Cell 2Breast Neoplasms 2Bone Neoplasms 2Back Pain 2Venous Thromboembolism 1Stomatitis 1Skin Neoplasms 1Renal Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia, Pneumococcal 1Pneumococcal Infections 1Peripheral Nervous System Diseases 1Pain 1Osteoporosis 1Osteonecrosis 1Osteolysis 1Myeloproliferative Disorders 1Multiple Sclerosis 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1

Interventions

Tablets 1Lenalidomide 1Fenofibrate 1Dexamethasone 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Peripheral Nervous System Diseases × Plasma cell × Clear all
NCT07025005 2025-11-04

VRd MM Fibrate

Tanta University

Phase 4 Recruiting
44 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡